Zepp Health

Zepp Health’s Q2 2025 earnings reveal a strong rebound, with revenue surging to US$59.4 million, a 46.2% year-over-year increase, surpassing company forecasts. Losses narrowed significantly, with GAAP net loss at US$7.7 million and adjusted net loss at US$6.16 million. The company projects Q3 2025 revenue between US$72 million and US$76 million, a 70-79% year-over-year increase. Key to this growth is the Amazfit brand, driven by new products like the Balance 2 and Helio Strap, and boosted by athlete endorsements and effective marketing.